[1]Ural A.Biomechanical mechanisms of atypical femoral fracture[J].J Mechanical Behavior Biomedical Materials,2021(124):104803.
[2]Rudran B,Super J,Jandoo R,et al.Current concepts in the management of bisphosphonate associated atypical femoral fractures[J].World J Orthop,2021,12(9):660-671.
[3]Shane E,Burr D,Abrahamsen B,et al.Atypical subtrochanteric and diaphyseal femoral fractures:second report of a task force of the american society for bone and mineral research[J].J Bone Mineral Res,2014,29(1):1-23.
[4]臧加成,马信龙.双膦酸盐相关性非典型股骨骨折临床诊疗进展[J].中华骨科杂志,2018,38(15):943-952.
[5]Ha Y,Cho M,Park KH,et al.Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?[J].Clin Orthop Relat Res,2010,468(12):3393-3398.
[6]Banffy MB,Vrahas MS,Ready JE,et al.Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures[J].Clin Orthop Relat Res,2011,469(7):2028-2034.
[7]Park Y,Yoon S,Yang KH.Localization of atypical femoral fracture on straight and bowed femurs[J].J Bone Metabolism,2019,26(2):123.
[8]Moran DS,Heled Y,Arbel Y,et al.Dietary intake and stress fractures among elite male combat recruits[J].J Int Soc Sports Nutr,2012,9(1):6.
[9]Tsuchie H,Miyakoshi N,Kasukawa Y,et al.The Serum 25(OH)D level in patients with atypical femoral fracture[J].Open Journal of Orthopedics,2018,8(9):331-336.
[10]Ng AC,Koh JSB,Howe TS.Vitamin D and atypical femoral fractures[J].Osteoporosis International,2013,24(5):1767.
[11]彭程,李凌,袁辉辉,等.老年人髋部骨密度与营养的相关性[J].实用医学杂志,2019,35(7):1124-1127.
[12]Liu ZM,Huang Q,Li SY,et al.A 1︰1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women[J].Osteoporos Int,2021,32(11):2205-2216.
[13]唐林,韦敏克,韦建勋,等.血管紧张素Ⅱ受体抑制剂对去卵巢骨质疏松小鼠腰椎骨组织的影响及可能机制[J].脊柱外科杂志,2018,16(3):157-162.
[14]常华,李琳,孟兆同,等.厄贝沙坦对中老年男性高血压病患者骨质代谢的影响[J].心脏杂志,2017,29(3):322-324.